Compared with baseline , scores in the RA arm improved significantly at week 8 on the CESD ( P = .022 ) , hot flash severity ( P = .006 ) , hot flash frequency ( P = .011 ) , the HFRDI ( P = .014 ) , and NSABP menopausal symptoms ( P = .022 ) ; scores in the SA arm improved significantly on the EuroQol ( P = .022 ) , the HFRDI ( P = .043 ) , and NSABP menopausal symptoms ( P = .005 ) .